Literature DB >> 9828433

The phylogeny of Ureaplasma urealyticum based on the mba gene fragment.

C L Knox1, P Giffard, P Timms.   

Abstract

Sequencing of mba gene fragments of reference strains of Ureaplasma urealyticum serovars 1, 3, 6, 14 and 8, in addition to 33 clinical U. urealyticum isolates is reported. A phylogenetic tree deduced from alignment of these sequences clearly demonstrates two major clusters (confidence limit 100%), which equate to the parvo and T960 biovars, and five types, which have been designated mba 1, 3, 6, 8 and X. These relationships are supported by bootstrap analysis. Polymorphisms within the mba fragment of types mba 1, 3 and 6 were used to define nine subtypes (mba 1a, 1b, 3a, 3b, 3c, 3d, 3e, 6a and 6b), thus facilitating high resolution typing of U. urealyticum. Inclusion of reference strains for serovars 1, 3, 6 and 8 in the mba typing scheme showed that the results of this analysis are broadly consistent with currently accepted serotyping. In addition, a ure gene fragment from nine of the clinical isolates was amplified and sequenced. Comparisons of the sequences clearly distinguished the two biovars of U. urealyticum; however, this fragment was invariant within the parvo biovar. This study has shown that the mba sequence can reveal the fine details of the relationships between U. urealyticum isolates and also supports the significant evolutionary gap between the two biovars.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9828433     DOI: 10.1099/00207713-48-4-1323

Source DB:  PubMed          Journal:  Int J Syst Bacteriol        ISSN: 0020-7713


  9 in total

1.  Differentiation of two biovars of Ureaplasma urealyticum based on the 16S-23S rRNA intergenic spacer region.

Authors:  R Harasawa; Y Kanamoto
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Simple method for determining biovar and serovar types of Ureaplasma urealyticum clinical isolates using PCR-single-strand conformation polymorphism analysis.

Authors:  D Pitcher; M Sillis; J A Robertson
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

Review 3.  The Human Ureaplasma Species as Causative Agents of Chorioamnionitis.

Authors:  Emma L Sweeney; Samantha J Dando; Suhas G Kallapur; Christine L Knox
Journal:  Clin Microbiol Rev       Date:  2016-12-14       Impact factor: 26.132

4.  Comparison of PCR, nested PCR, and random amplified polymorphic DNA PCR for detection and typing of Ureaplasma urealyticum in specimens from pregnant women.

Authors:  C L Knox; P Timms
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

5.  Extensive horizontal gene transfer in ureaplasmas from humans questions the utility of serotyping for diagnostic purposes.

Authors:  Li Xiao; Vanya Paralanov; John I Glass; Lynn B Duffy; Janet A Robertson; Gail H Cassell; Yuying Chen; Ken B Waites
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

6.  Detection and characterization of human Ureaplasma species and serovars by real-time PCR.

Authors:  Li Xiao; John I Glass; Vanya Paralanov; Shibu Yooseph; Gail H Cassell; Lynn B Duffy; Ken B Waites
Journal:  J Clin Microbiol       Date:  2010-06-16       Impact factor: 5.948

7.  Comparative genome analysis of 19 Ureaplasma urealyticum and Ureaplasma parvum strains.

Authors:  Vanya Paralanov; Jin Lu; Lynn B Duffy; Donna M Crabb; Susmita Shrivastava; Barbara A Methé; Jason Inman; Shibu Yooseph; Li Xiao; Gail H Cassell; Ken B Waites; John I Glass
Journal:  BMC Microbiol       Date:  2012-05-30       Impact factor: 3.605

8.  Ureaplasma antigenic variation beyond MBA phase variation: DNA inversions generating chimeric structures and switching in expression of the MBA N-terminal paralogue UU172.

Authors:  Carl-Ulrich R Zimmerman; Renate Rosengarten; Joachim Spergser
Journal:  Mol Microbiol       Date:  2010-12-08       Impact factor: 3.501

9.  Spread of multidrug resistance among Ureaplasma serovars, Tunisia.

Authors:  Safa Boujemaa; Béhija Mlik; Amina Ben Allaya; Helmi Mardassi; Boutheina Ben Abdelmoumen Mardassi
Journal:  Antimicrob Resist Infect Control       Date:  2020-01-23       Impact factor: 4.887

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.